A B Skotnicki
- Hematology top 5%
- Genetics top 5%
- Oncology
- Pathology and Forensic Medicine top 10%
- Molecular Biology
- Co-authors
- Anna DmoszyńskaTadeusz RobakJerzy HołowieckiMarcelo B. SzteinL KonopkaJadwiga Dwilewicz‐TrojaczekCheryl SamuelsAndrzej Hellmann
- Topics
- Chronic Lymphocytic Leukemia Research (16 papers)Lymphoma Diagnosis and Treatment (14 papers)Immunodeficiency and Autoimmune Disorders (7 papers)
- Partner nations
- PolandUnited StatesCzechia
In The Last Decade
A B Skotnicki
45 papers receiving 564 citations
Peers
Comparison fields: 5 of 70
- Hematology 252
- Genetics 211
- Oncology 146
- Pathology and Forensic Medicine 138
- Molecular Biology 132
Countries citing papers authored by A B Skotnicki
This map shows the geographic impact of A B Skotnicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A B Skotnicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A B Skotnicki more than expected).
Fields of papers citing papers by A B Skotnicki
This network shows the impact of papers produced by A B Skotnicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A B Skotnicki. The network helps show where A B Skotnicki may publish in the future.
Co-authorship network of co-authors of A B Skotnicki
This figure shows the co-authorship network connecting the top 25 collaborators of A B Skotnicki. A scholar is included among the top collaborators of A B Skotnicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A B Skotnicki. A B Skotnicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | QUALITY OF LIFE IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA PATIENTS TREATED WITH LENALIDOMIDE VS INVESTIGATOR'S CHOICE: MCL-002 (SPRINT) TRIAL | 2 |
| 2 | SAFETY AND EFFICACY OF RUXOLITINIB (RUX) IN PATIENTS WITH INTERMEDIATE-1-RISK MYELOFIBROSIS (MF) FROM AN OPEN-LABEL, MULTICENTER, SINGLE-ARM EXPANDED-ACCESS STUDY | 5 |
| 3 | 13 | |
| 4 | 39 | |
| 5 | 29 | |
| 6 | 5 | |
| 7 | 13 | |
| 8 | 13 | |
| 9 | 2 | |
| 10 | 9 | |
| 11 | 22 | |
| 12 | 46 | |
| 13 | 0 | |
| 14 | 21 | |
| 15 | 32 | |
| 16 | [Hemorrhagic cystitis related to the high-dose conditioning therapy in a bone marrow recipient]. | 1 |
| 17 | [Methods for freezing, thawing and viability estimation of hemopoietic stem cells]. | 8 |
| 18 | 13 | |
| 19 | 19 | |
| 20 | [Various aspects of immunopathogenesis of multiple sclerosis and therapeutic possibilities]. | 1 |
About A B Skotnicki
A B Skotnicki is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 49 papers that have together received 585 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (16 papers), Lymphoma Diagnosis and Treatment (14 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). The work is most often cited by research in Hematology (252 citations), Genetics (211 citations) and Pathology and Forensic Medicine (138 citations). A B Skotnicki has collaborated with scholars based in Poland, United States and Czechia. Frequent co-authors include Anna Dmoszyńska, Tadeusz Robak, Jerzy Hołowiecki, Marcelo B. Sztein, L Konopka, Jadwiga Dwilewicz‐Trojaczek, Cheryl Samuels, Andrzej Hellmann, Goldstein Al and Marek Hus. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.